Elutia Inc (ELUT) vs Grace Therapeutics, Inc. (GRCE)
A side-by-side comparison of Elutia Inc and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELUT
Elutia Inc
$0.77HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
GRCE
Grace Therapeutics, Inc.
$2.13HealthcareDelayed quote: Oct 6, 2026, 1:44 PM EDT
Total return — ELUT vs GRCE
growth of $100 · dividends reinvested · last 2yELUT -78.5% (-53.7%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
ELUT GRCE
ELUT vs GRCE: by the numbers
- •GRCE is the larger company ($35M vs $34M market cap).
- •ELUT is profitable (426.93% net margin) while GRCE runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ELUT | GRCE |
|---|---|---|
| P/E ratio | 0.82 | N/A |
| P/S ratio | 2.81 | N/A |
| P/B ratio | 2.16 | 0.72 |
Profitability
| Metric | ELUT | GRCE |
|---|---|---|
| Gross margin | 57.82% | 0.00% |
| Operating margin | -149.78% | 0.00% |
| Net margin | 426.93% | 0.00% |
| ROE | 329.02% | -44.50% |
| ROIC | -79.27% | -52.61% |
Growth (annualized)
| Metric | ELUT | GRCE |
|---|---|---|
| Revenue CAGR (5Y) | -22.04% | N/A |
| Total return CAGR (5Y) | -33.96% | N/A |
Frequently asked
- Is ELUT or GRCE more profitable?
- ELUT runs the higher net margin — ELUT at 426.93% versus GRCE at 0.00%.
Go deeper
Dig into the metrics
Elutia P/E ratioElutia ROEGrace Therapeutics ROEElutia operating marginGrace Therapeutics operating marginElutia revenue growthGrace Therapeutics revenue growthElutia free cash flowGrace Therapeutics free cash flow
Elutia & Grace Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.